

| Catalog No. | DW759018 |
|---|---|
| Description |
Lirilumab ELISA Kit (DW759018) — Quantitative sandwich ELISA for Lirilumab. Sample: Plasma, Serum. Range: 0.31-5 μg/mL. Sensitivity: 0.156 μg/ml.
Highlights
|
| Sample type | Serum, plasma, and other biological fluid samples |
| Sensitivity | 15.09 ng/mL |
| Range | 31.25 - 2,000 ng/mL |
| Species reactivity | Human |
| Target | CD158 antigen-like family member A,KIR2DL1,Killer cell immunoglobulin-like receptor 2DL1,Natural killer-associated transcript 1,NKAT-1,MHC class I NK cell receptor,CD158A,p58 natural killer cell receptor clones CL-42/47.11 |
| Accession | P43626,P43627,P43628 |
| Applications | ELISA |
| Detection method | Colorimetric |
| Assay type | Competitive |
| Recovery | 80-120% |
| Shipping | 2-8 ℃ |
| Stability and Storage | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
| Specifications | Lirilumab |
| Alternate Names | BMS-986015, IPH2102, 1000676-41-4 |
| Background | Lirilumab (IPH2102/BMS-986015/BMS-986015-01) is a fully human monoclonal antibody (mAb) that is designed to block the interaction between KIR2DL-1, -2, -3 inhibitory receptors and their ligands. This drug was developed by Innate Pharma and is licensed to Bristol-Myers Squibb. A phase 2 clinical trial for acute myeloid leukemia (AML) was terminated early ( |
| Note | For Research Use Only. |

Standard Curve of Lirilumab ELISA Kit
Contact us for custom quotes, bulk requests and any other issues.
Mail: [email protected]


Quick access
Contact Us
+86-27-65523339
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский